We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Top Buys

Rank Stock Value
1
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$11.4M
2
XLRE icon
State Street Real Estate Select Sector SPDR ETF
XLRE
+$10.4M
3
WBD icon
Warner Bros
WBD
+$7.05M
4
VUSB icon
Vanguard Ultra-Short Bond ETF
VUSB
+$6.7M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$6.27M

Top Sells

Rank Stock Value
1
SGOL icon
abrdn Physical Gold Shares ETF
SGOL
+$12.8M
2
AAPL icon
Apple
AAPL
+$7.91M
3
SPHB icon
Invesco S&P 500 High Beta ETF
SPHB
+$7.88M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.62M
5
FCN icon
FTI Consulting
FCN
+$6.61M

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UXIN
1351
Uxin Ltd
UXIN
$308M
$77K ﹤0.01%
1,830
– –
TRHC
1352
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$77K ﹤0.01%
29,875
-144
-0.5% -$540
ERAS icon
1353
Erasca
ERAS
$6.13B
$73K ﹤0.01%
13,144
– –
ATXS
1354
DELISTED
Astria Therapeutics
ATXS
$71K ﹤0.01%
23,616
– –
PPT
1355
Franklin Premier Income Trust
PPT
$327M
$71K ﹤0.01%
18,600
– –
NAGE
1356
Niagen Bioscience
NAGE
$279M
$65K ﹤0.01%
39,110
+21,900
+127% +$42.8K
MNKD icon
1357
MannKind Corp
MNKD
$1.2B
$64K ﹤0.01%
16,800
-1,500
-8% -$5.51K
NLY icon
1358
Annaly Capital Management
NLY
$17.3B
$64K ﹤0.01%
2,731
-17,974
-87% -$466K
FEMY icon
1359
Femasys
FEMY
$8.64M
$58K ﹤0.01%
1,193
– –
TCRT icon
1360
Alaunos Therapeutics
TCRT
$4.69M
$56K ﹤0.01%
303
-170
-36% -$16.2K
RGTI icon
1361
Rigetti Computing
RGTI
$5.3B
$55K ﹤0.01%
+15,000
New +$95.3K
ADIL
1362
Adial Pharmaceuticals
ADIL
$7.4M
$52K ﹤0.01%
62
– –
BNGO icon
1363
Bionano Genomics
BNGO
$12.6M
$52K ﹤0.01%
63
-47
-43% -$48.4K
APPH
1364
DELISTED
AppHarvest, Inc. Common Stock
APPH
$50K ﹤0.01%
14,300
+1,500
+12% +$5.38K
IS
1365
DELISTED
ironSource Ltd.
IS
$50K ﹤0.01%
+20,800
New +$69.6K
RIGL icon
1366
Rigel Pharmaceuticals
RIGL
$685M
$48K ﹤0.01%
4,259
-1,065
-20% -$21.4K
FAX
1367
DELISTED
abrdn Asia-Pacific Income Fund
FAX
$44K ﹤0.01%
15,000
+3,000
+25% +$8.8K
GEG icon
1368
Great Elm Group
GEG
$67.4M
$44K ﹤0.01%
20,510
+7,419
+57% +$14.9K
MLSS icon
1369
Milestone Scientific
MLSS
$36.4M
$43K ﹤0.01%
47,500
– –
FUBO icon
1370
FuboTV Inc
FUBO
$279M
$40K ﹤0.01%
1,341
+165
+14% +$7.69K
RVP icon
1371
Retractable Technologies
RVP
$20.1M
$38K ﹤0.01%
+10,020
New +$41K
CFMS
1372
DELISTED
Conformis, Inc. Common Stock
CFMS
$38K ﹤0.01%
4,283
+62
+1% +$708
TOON icon
1373
Kartoon Studios
TOON
$35.4M
$37K ﹤0.01%
4,880
– –
BFLY icon
1374
Butterfly Network
BFLY
$2.1B
$36K ﹤0.01%
11,700
-2,000
-15% -$6.91K
CGC
1375
Canopy Growth
CGC
$394M
$36K ﹤0.01%
1,266
-764
-38% -$39.7K
53 54
55
56 57

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.